https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Increased risk of suicide in New South Wales men with prostate cancer: analysis of linked population-wide data https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32834 Wed 19 Jan 2022 15:17:36 AEDT ]]> Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51025 Wed 16 Aug 2023 10:02:34 AEST ]]> Lung cancer treatment patterns and factors relating to systemic therapy use in Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46698 Wed 13 Mar 2024 08:07:19 AEDT ]]> Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19681 Wed 11 Apr 2018 14:42:48 AEST ]]> Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30808 Wed 11 Apr 2018 12:31:21 AEST ]]> Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15136 Wed 11 Apr 2018 09:13:41 AEST ]]> New challenges in psycho-oncology research III: a systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33370 Wed 09 Feb 2022 15:55:29 AEDT ]]> Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48997 35 cigarettes/day. Lung cancer risk was lower with quitting at any age but remained higher than never-smokers for quitters aged >25y. By age 80y, an estimated 48.3% of current-smokers (41.1% never-smokers) will develop cancer, and 14% will develop lung cancer, including 7.7% currently smoking 1-5 cigarettes/day and 26.4% for >35 cigarettes/day (1.0% never-smokers). Cancer risk for Australian smokers is significant, even for 'light' smokers. These contemporary estimates underpin the need for continued investment in strategies to prevent smoking uptake and facilitate cessation, which remain key to reducing cancer morbidity and mortality worldwide.]]> Wed 03 May 2023 12:03:16 AEST ]]> Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33342 Thu 28 Oct 2021 13:04:32 AEDT ]]> Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45346 Thu 27 Oct 2022 10:29:08 AEDT ]]> Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36717 Thu 09 Dec 2021 11:03:35 AEDT ]]> Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35014 Thu 09 Dec 2021 11:01:40 AEDT ]]> Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51488 Thu 07 Sep 2023 10:52:02 AEST ]]> Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33626 Thu 03 Feb 2022 12:22:13 AEDT ]]> Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21369 Sat 24 Mar 2018 07:51:25 AEDT ]]> Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: results from an observational study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28048 Sat 24 Mar 2018 07:41:01 AEDT ]]> Urologists’ referral and radiation oncologists’ treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41232 P < 0.001). Conclusion: Only 30% of patients with high-risk features are referred to a radiation oncologist with the likelihood of referral being influenced by the perceived risk of cancer-recurrence as well as the urologist’s institutional/personal preference. When patients are seen by a radiation oncologist, 61% receive radiotherapy within 6 months after RP with the likelihood of receiving radiotherapy not being heavily influenced by increasing risk of recurrence. This suggests many suitable patients would receive radiotherapy if referred and seen by a radiation oncologist.]]> Fri 29 Jul 2022 13:51:38 AEST ]]> A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44096 p < 0.001). After adjustment, there was no significant difference in referral to radiation oncology (intervention 32% vs control 30%; adjusted RR=1.06; 95% CI [0.74 to 1.51]; p=0.879). Sites with the largest relative increases in the percentage of patients discussed also tended to have greater increases in referral (p=0.001). In the intervention phase, urologists failed to provide referrals to more than half of patients whom the MDT had recommended for referral (78 of 140; 56%). Conclusions: The intervention resulted in significantly more patients being discussed by a MDT. However, the recommendations from MDTs were not uniformly recorded or followed. Although practice varied markedly between MDTs, the intervention did not result in a significant overall change in referral rates, probably reflecting a lack of change in urologists' attitudes. Our results suggest that interventions focused on structures and processes that enable health system-level change, rather than those focused on individual-level change, are likely to have the greatest effect.]]> Fri 07 Oct 2022 08:50:21 AEDT ]]>